Pharma & Biotech
2022 IP Profiles Survey28 February 2022
In September, Asia IP will publish the 2022 edition of Asia IP Profiles. This guide is the definitive resource for companies trying to identify the best IP practices in the region, and is based on editorial research, and surveys submitted by leading...
Chatbots: A way to immortalize the dead?28 February 2022
When Microsoft secured a patent for conversational chatbots to mine data from a person’s social media history, observers wondered how it might affect the person’s intellectual property rights
Brain interfacing, copyright and the patent system28 February 2022
Brain interfacing has been gaining traction since Elon Musk’s investment in Neuralink. Lawyers discuss how future brain-computer collaborations might affect copyright and patent laws.
The Winners of the Asia IP 2021 Awards17 January 2022
You have spoken. The verdict is in. And the winners are...
Asia IP’s editorial team reveals India’s top IP firms, practices30 November 2021
And the winners of the 2021 Asia IP India Awards are...
IPOPHL collaborates with the Pharmaceutical Security Institute to combat the rise of counterfeit pha...30 November 2021
The ayes and nays of ‘covered’ and ‘disclosed’ in a patent31 August 2021
AstraZeneca AB filed an application at the Delhi High Court seeking an interim injunction for restraining Emcure Pharmaceuticals Ltd. from making, selling, distributing, exporting or offering for sale products comprising the compound Ticagrelor under...
Patentability of inventions relating to dosing regimen in China31 August 2021
Although methods for the diagnosis and treatment of diseases are not granted patent rights in China, the CNIPA will allow an applicant to seek protection for inventions relating to the second medical use of a substance. Jiancheng Jiang explains the i...
Number of IP Filings In The Philippines Increaes By 20% In First Half30 August 2021
The total number of IP applications was 22,919. The most significant rise was in utility model (UM) submissions, which increased by 26% from 592 to 744 between January and June of last year.
Favipiravir: Patent rejection in Thailand31 July 2021
Thailand’s Department of Intellectual Property (DIP) has since rejected a Thai patent application filed under the compulsory license system for a specific formulation Favipiravir in tablet form.
One of Taiwan’s new Covid-19 vaccines can be a game changer05 July 2021
A local expert dissects one of the patent applications and provides updates on other vaccines that are currently being developed in the jurisdiction.